-transparent.png){kind=logo}
A cloned DNA fragment related to pT17 containing a partial cDNA sequence of human terminal deoxynucleotidyl transferase was used as a probe to screen for the full length cDNA sequence of the enzyme in a lambda gt11 library constructed from human lymphoblastoid KM-3 cDNA. A recombinant containing a 2068-base pair insert was isolated and recloned into the EcoRI site of the sequencing plasmic pUC-8 as two subclones, pT711 and pT106. DNA sequencing and hybridization studies showed that pT711 contains the pT17 sequence and an additional 172 upstream nucleotides. pT711 represents the coding sequence for the carboxyl half of the terminal transferase protein. pT106, containing a 965-base pair insert, hybridizes to the same mRNA as pT711 on Northern blots and contains an open reading frame that is in phase with the reading frame of the insert in pT711. Amino acid sequencing of the 58-kDa peptide of the calf thymus terminal transferase failed, indicating that the N terminus is blocked. N-Terminal sequencing of a 56-kDa form of the protein produced 24 amino acids corresponding to the translated human cDNA coding sequence starting at residue 398 of the insert in pT106 with 83% homology between bovine and human sequence. The initiation codon is assigned to an ATG sequence at nucleotide 329 of the insert in pT106. Comparison of the translated human terminal transferase sequence with peptides from the calf thymus enzyme showed that the homology between the human and bovine enzyme is better than 90% among 263 amino acids determined. The coding sequences in pT106 and pT711 were recloned into an expression plasmid pUC-19 downstream from the lac promoter and in phase with the coding sequence of the lac Z gene. Lysates of bacteria carrying the reconstructed coding sequence of human terminal transferase contain a fused protein of 60 kDa that reacts with rabbit antibody to terminal transferase on immunoblots and exhibits enzyme activity. Isolation of this fused protein from bacterial lysates with mouse monoclonal antibody to human terminal transferase produces the expected protein of 60 kDa.
R C Peterson, and
L C Cheung, and
R J Mattaliano, and
S T White, and
L M Chang, and
F J Bollum
November 1976,
Journal of neurochemistry,
R C Peterson, and
L C Cheung, and
R J Mattaliano, and
S T White, and
L M Chang, and
F J Bollum
August 1978,
Lancet (London, England),
R C Peterson, and
L C Cheung, and
R J Mattaliano, and
S T White, and
L M Chang, and
F J Bollum
October 1981,
Human pathology,
R C Peterson, and
L C Cheung, and
R J Mattaliano, and
S T White, and
L M Chang, and
F J Bollum
January 1980,
American journal of clinical pathology,
R C Peterson, and
L C Cheung, and
R J Mattaliano, and
S T White, and
L M Chang, and
F J Bollum
June 1978,
Haematologica,
R C Peterson, and
L C Cheung, and
R J Mattaliano, and
S T White, and
L M Chang, and
F J Bollum
April 1975,
Research communications in chemical pathology and pharmacology,
R C Peterson, and
L C Cheung, and
R J Mattaliano, and
S T White, and
L M Chang, and
F J Bollum
January 1982,
Advances in experimental medicine and biology,
R C Peterson, and
L C Cheung, and
R J Mattaliano, and
S T White, and
L M Chang, and
F J Bollum
December 1983,
American journal of clinical pathology,
R C Peterson, and
L C Cheung, and
R J Mattaliano, and
S T White, and
L M Chang, and
F J Bollum
March 1995,
Nihon rinsho. Japanese journal of clinical medicine,
R C Peterson, and
L C Cheung, and
R J Mattaliano, and
S T White, and
L M Chang, and
F J Bollum
December 2004,
Nihon rinsho. Japanese journal of clinical medicine,
